Skin of Color Update 30% Off Registration, Use Code: JDD30
Skip to main content
Atopic DermatitisFeatured ArticlesJDD HiglightsLatest News

JDD October 2026 Highlights and Editor Picks

By October 20, 2026No Comments

Curated by the JDD Editors

Missed any of our October highlights? September is our Atopic Dermatitis issue and is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated roundup from the JDD Editors. This is your guide to must-read articles for the derm community.

OCTOBER ISSUE

The Essential Role of Topical Targeted Therapy in Atopic Dermatitis highlights the ongoing role of topical treatments in AD management. 

Off-Label Uses of Nemolizumab: A Narrative Review supports nemolizumab as a promising therapeutic option for treatment-refractory pruritic conditions. 

Biologics and Small-Molecule Inhibitors for the Treatment of Nummular Eczema: A Systematic Review supports dupilumab and tralokinumab for the treatment of NE. 

Fundamentals of Hyperpigmentation Disorders: Causes, Concerns, and Treatment Strategies, Particularly in Skin of Color Patients discusses the need for routine assessment of patient-reported quality-of-life impact when treating this disorder. 

Contact Allergens Associated With Nummular Eczema: A Systematic Review

Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study reports rates vary across studies, and how these differences likely reflect differences in geography, patient population, and patch test series used. 

Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series shares how this treatment was associated with improvements in facial skin quality in women with estrogen deficiency who were not receiving hormone therapy.